Cite
HARVARD Citation
Gruber, M. et al. (2020). P300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer. Endocrine-related cancer. 27 (3), pp. 187-198. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gruber, M. et al. (2020). P300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer. Endocrine-related cancer. 27 (3), pp. 187-198. [Online].